Vitamin D supplementation for treating acne
Vitamin D Supplementation in Combination With Azithromycin and Topical Retinoid for Acne: A Randomized Controlled Trial
This study tests if adding vitamin D supplements to standard acne treatments can help people aged 13 to 40 see better results in just two months.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 58 (estimated) |
| Ages | 13 Years to 40 Years |
| Sex | All |
| Sponsor | HITEC-Institute of Medical Sciences Academic / other |
| Locations | 1 site (Islamabad, Punjab Province) |
| Trial ID | NCT06141330 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of vitamin D supplements in treating acne vulgaris. Participants aged 13 to 40 will receive vitamin D in addition to standard treatments, which include azithromycin and topical retinoid. The study will compare the outcomes of those receiving vitamin D with those receiving conventional treatment alone over a two-month period. The goal is to determine if vitamin D can enhance the therapeutic benefits for patients with acne.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 13 to 40 diagnosed with acne vulgaris.
Not a fit: Patients currently undergoing treatment for polycystic ovary syndrome, obesity, or those using vitamin supplementation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new adjunctive treatment option for patients suffering from acne vulgaris.
How similar studies have performed: While there is limited research specifically on vitamin D for acne, similar studies on vitamin supplementation have shown promising results in other dermatological conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included. Exclusion Criteria: * Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs) * Those with obesity * Individuals employing vitamin supplementation * Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.
Where this trial is running
Islamabad, Punjab Province
- Hitec-Ims — Islamabad, Punjab Province, Pakistan (Recruiting)
Study contacts
- Study coordinator: Aqsa Naheed, MBBS
- Email: aqsanahid@gmail.com
- Phone: 0323-6513804
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.